Morgan Stanley’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Buy |
587,676
+232,500
| +65% | +$574K | ﹤0.01% | 4906 |
|
|
2025
Q1 | $707K | Buy |
355,176
+43,900
| +14% | +$87.4K | ﹤0.01% | 5173 |
|
|
2024
Q4 | $909K | Buy |
311,276
+10,885
| +4% | +$31.8K | ﹤0.01% | 5142 |
|
|
2024
Q3 | $1.16M | Buy |
300,391
+116,426
| +63% | +$451K | ﹤0.01% | 4963 |
|
|
2024
Q2 | $946K | Sell |
183,965
-14,501
| -7% | -$74.5K | ﹤0.01% | 4993 |
|
|
2024
Q1 | $1.39M | Sell |
198,466
-225,002
| -53% | -$1.58M | ﹤0.01% | 4788 |
|
|
2023
Q4 | $3.75M | Buy |
423,468
+380,677
| +890% | +$3.37M | ﹤0.01% | 4547 |
|
|
2023
Q3 | $408K | Sell |
42,791
-15,138
| -26% | -$144K | ﹤0.01% | 5256 |
|
|
2023
Q2 | $849K | Buy |
57,929
+24,544
| +74% | +$360K | ﹤0.01% | 4928 |
|
|
2023
Q1 | $411K | Buy |
33,385
+12,996
| +64% | +$160K | ﹤0.01% | 5366 |
|
|
2022
Q4 | $379K | Buy |
+20,389
| New | +$379K | ﹤0.01% | 5378 |
|